Alberto Diniz-Filho, None;
Linda Zangwill, Carl Zeiss Meditec Inc. (F), Carl Zeiss Meditec Inc. (R), Heidelberg Engineering GmbH (F), Optovue Inc. (F), Optovue Inc. (R), Quark (F), Topcon Inc. (F);
Akram Belghith, None;
Robert Weinreb, Alcon Inc. (C), Allergan Inc. (C), Bausch + Lomb (C), Carl Zeiss Meditec Inc. (C), Carl Zeiss Meditec Inc. (F), Carl Zeiss Meditec Inc. (R), Genentech (F), Heidelberg Engineering GmbH (F), Optovue Inc. (F), Topcon Inc. (C), Topcon Inc. (F);
Felipe Medeiros, Alcon Inc. (F), Alcon Inc. (R), Allergan Inc. (C), Allergan Inc. (F), Allergan Inc. (R), Bausch + Lomb (F), Carl Zeiss Meditec Inc. (C), Carl Zeiss Meditec Inc. (F), Carl Zeiss Meditec Inc. (R), Heidelberg Engineering GmbH (F), Merck Inc. (F), National Eye Institute (F), Novartis (C), Reichert Inc. (R), Reichert Inc. (F), Sensimed (F), Topcon Inc. (F)